Colfax Corporation

39.0600.00Vol -1Y Perf -9.75%
Apr 4th, 2022 16:00 DELAYED
BID0.00 ASK0.00
Open0.00 Previous Close39.06
Pre-Market- After-Market-
 - -  - -%
Target Price
51.11 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
★★+ —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+ —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
0.00 
Earnings Rating
Buy
Market Cap2.10B 
Earnings Date
5th May 2022
Alpha-0.02 Standard Deviation0.12
Beta2.13 

Today's Price Range

0.000.00

52W Range

-186.13-131.00

5 Year PE Ratio Range

-3.20176.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-
1 Month
0.00%
3 Months
-5.49%
6 Months
-23.38%
1 Year
-9.75%
3 Years
45.20%
5 Years
-1.51%
10 Years
45.20%

TickerPriceChg.Chg.%
CFX39.060.00000.00
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
1.30
2.30
0.33
0.49
3.30
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
41.90
6.20
13.00
2.40
1.88
RevenueValueIndustryS&P 500US Markets
2.98B
55.32
-1.25
-0.29
Earnings HistoryEstimateReportedSurprise %
Q04 20210.570.593.51
Q03 20210.540.540.00
Q02 20210.530.565.66
Q01 20210.390.4412.82
Q04 20200.490.514.08
Q03 20200.400.412.50
Q02 20200.060.0950.00
Q01 20200.370.382.70
Earnings Per EndEstimateRevision %Trend
3/2022 QR0.49-15.52Negative
6/2022 QR0.60-13.04Negative
12/2022 FY2.39-6.64Negative
12/2023 FY2.68-6.94Negative
Next Report Date-
Estimated EPS Next Report0.49
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume0
Shares Outstanding53.78K
Shares Float136.18M
Trades Count0
Dollar Volume0
Avg. Volume1.29M
Avg. Weekly Volume0
Avg. Monthly Volume0
Avg. Quarterly Volume1.29M

Colfax Corporation (NYSE: CFX) stock closed at 39.06 per share at the end of the most recent trading day (a -3% change compared to the prior day closing price) with a volume of 21.38K shares and market capitalization of 2.10B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Industrial Products industry, Industrials sector and employs 15400 people. Colfax Corporation CEO is Matthew L. Trerotola.

The one-year performance of Colfax Corporation stock is -9.75%, while year-to-date (YTD) performance is -15.03%. CFX stock has a five-year performance of -1.51%. Its 52-week range is between -186.130842 and -130.999218, which gives CFX stock a 52-week price range ratio of %

Colfax Corporation currently has a PE ratio of 90.20, a price-to-book (PB) ratio of 1.42, a price-to-sale (PS) ratio of 0.71, a price to cashflow ratio of 17.70, a PEG ratio of 2.32, a ROA of 0.90%, a ROC of 1.79% and a ROE of 1.76%. The company’s profit margin is 1.88%, its EBITDA margin is 13.00%, and its revenue ttm is $2.98 Billion , which makes it $55.32 revenue per share.

Of the last four earnings reports from Colfax Corporation, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.49 for the next earnings report. Colfax Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Colfax Corporation is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Colfax Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Colfax Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Colfax Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 22.02, ATR14 : 1.29, CCI20 : 17.90, Chaikin Money Flow : 0.10, MACD : -0.07, Money Flow Index : 49.91, ROC : -2.76, RSI : 49.31, STOCH (14,3) : 35.99, STOCH RSI : 0.20, UO : 42.18, Williams %R : -64.01), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Colfax Corporation in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (60.00 %)
6 (60.00 %)
8 (72.73 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (30.00 %)
3 (30.00 %)
2 (18.18 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (10.00 %)
1 (10.00 %)
1 (9.09 %)
Summary Rating-
0.00
-
0.00
-
0.00

Colfax Corporation

Colfax is a diversified technology firm that produces welding equipment and medical devices. Following the sale of its air and gas handling business in 2019, Colfax's remaining portfolio is organized into two segments: fabrication technology and medical technology. Fabrication technology is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications, mostly marketed under the ESAB brand name. The medical technology segment makes medical devices, including orthopedic braces, reconstructive implants, and other products used for rehabilitation, physical therapy, and pain management. The company generated roughly $3.1 billion in revenue in 2020.

CEO: Matthew L. Trerotola

Telephone: +1 301 323-9000

Address: 420 National Business Parkway, Annapolis Junction 20701, MD, US

Number of employees: 15 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

64%36%

Bearish Bullish

54%46%

TipRanks News for CFX

Sun, 03 Apr 2022 16:43 GMT Colfax (CFX) Receives a Buy from Robert W. Baird

- TipRanks. All rights reserved.

News

Stocktwits